Dr José Nasser MD PHD Substack

Dr José Nasser MD PHD Substack

Share this post

Dr José Nasser MD PHD Substack
Dr José Nasser MD PHD Substack
Depoimento de IVERMECTINA e FENBENDAZOL - Paciente com câncer de bexiga urotelial estágio 4 de 75 anos com metástases nos pulmões, fígado, ossos e gânglios linfáticos tem melhora dramática no PET/CT!

Depoimento de IVERMECTINA e FENBENDAZOL - Paciente com câncer de bexiga urotelial estágio 4 de 75 anos com metástases nos pulmões, fígado, ossos e gânglios linfáticos tem melhora dramática no PET/CT!

Assine e leia tudo no meu Substack. Link na Bio

Dr J Nasser MD and PHD's avatar
Dr J Nasser MD and PHD
Mar 24, 2025
∙ Paid
2

Share this post

Dr José Nasser MD PHD Substack
Dr José Nasser MD PHD Substack
Depoimento de IVERMECTINA e FENBENDAZOL - Paciente com câncer de bexiga urotelial estágio 4 de 75 anos com metástases nos pulmões, fígado, ossos e gânglios linfáticos tem melhora dramática no PET/CT!
Share

Dr José Nasser MD PHD Substack is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Keep reading with a 7-day free trial

Subscribe to Dr José Nasser MD PHD Substack to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 jose augusto nasser md phd
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share